   body {font-family: 'Open Sans', sans-serif;}

table { width: 100%; } table caption { text-align: left; } table thead th { text-align: left; } table td { text-align: left; padding: 6px; width: 100%; border-bottom-style: ridge; border-bottom-width: thin; border-bottom-color: Gray; } table th { text-align: left; padding: 6px; white-space: nowrap; border-bottom-style: ridge; border-bottom-width: thin; border-bottom-color: Gray; }

# Dobutamine (Dobutrex) Notes 1

Synthetic catecholamine (beta-1 agonist). Increases contractility and to a lesser extent heart rate. Little direct effect on BP.

**Uses**: refractory CHF or hypotensive patients in whom vasodilators cannot be used because of effects on BP.

* * *

**Class:** Sympathomimetic.

* * *

**Actions:** Increases cardiac contractility, little chronotropic activity. peripheral vasoconstriction, decreasing peripheral perfusion potent non-selective beta agonist also an alpha agonist (Beta>alpha)

* * *

**Indications:** Short-term management of congestive heart failure.

* * *

**Contraindications:** Should only be used in patients with an adequate heart rate.

* * *

**Precautions:** Ventricular irritability. Use with caution following myocardial infarction. Can be deactivated by alkaline solutions.

* * *

**Side Effects:** Increased heart rate, palpitations.

* * *

**Dosage:** 2.5-20 ug/kg/minute.

* * *

**Routes:** IV drip.

* * *

**Pediatric Dosage:** 2 - 20 ug/kg/min.

* * *

**Onset of action:** 1-10 minutes.  
**Peak effect:** 10-20 minutes.  

* * *

**Half-life:** 2 minutes.

**Excretion:** Urine (as metabolites).

* * *

**Adult Dose (usual):** 2.5 to 20 mcg/kg/minute.

**Maximum:** 40 mcg/kg/min. Titrate to desired response. Administer into large vein. Usual doses to increase cardiac output are 2.5 to 15 mcg/kg/minute IV.